News summary
[Dongcheng Pharmaceutical: Its holding subsidiary obtains approval notice for drug clinical trials] Securities Times e Company News, Dongcheng Pharmaceutical (002675) announced on the evening of May 24. On May 23, the company's holding subsidiary Yantai Lannacheng Biotechnology Co., Ltd. received approval and issuance from the State Food and Drug AdministrationdigitalroulettewheelAbout 177digitalroulettewheel...
Newsletter text
[Dongcheng Pharmaceutical: Holding subsidiary obtains drug clinical trial approval notice] Securities Times e Company News, Dongcheng Pharmaceutical (002675) announced on the evening of May 24. On May 23, the company's holding subsidiary Yantai Lannacheng Biotechnology Co., Ltd. received the drug clinical trial approval notice for 177Lu-LNC1010 injection approved and issued by the State Food and Drug Administration, agreeing to carry out clinical trials of gastrointestinal and pancreatic neuroendocrine tumors.